BioCentury
ARTICLE | Strategy

Connecting dots in diabetes

How Sanofi-Verily JV Onduo could improve day-to-day management of diabetes

September 19, 2016 7:00 AM UTC

The Onduo JV launched last week by Sanofi and Verily Life Sciences LLC is not providing much detail on the products and services it plans to develop, but what it has said about integrating disparate components of diabetes care could help address gaps in day-to-day disease management that patient groups want help with.

The JV expands upon an August 2015 deal between Sanofi and Verily (formerly Google Life Sciences) to develop tools for diabetes that would reduce the risk of complications, improve patient outcomes and lower the cost of care. The JV will seek to develop a disease-management platform that integrates treatment, devices and personalized, data-driven patient support to reduce the burden of managing the disease...